14.09.2018 08:14:00
|
Medicover Acquires Leading Genetics Laboratory in Germany
STOCKHOLM, Sept. 14, 2018 /PRNewswire/ --
Medicover has signed an agreement to acquire the centre for genetic diagnostics of Dr. Klein, Dr. Rost and colleagues as well as its affiliate IMGM, both located in Martinsried, near Munich, Germany. The laboratory has a strong position within genetic testing, pathology, transfusion medicine, microbiology and virology and will accordingly enhance Medicover's offering within these areas. The acquisition will as well create a platform for further expansion in southern Germany.
Revenue for the laboratory amounted to around 17 million euro in 2017 with a total number of employees of 160. The transaction is subject to merger control clearance and regulatory approvals with closing expected in January 2019.
For further information, please contact:
Paula Treutiger, Corporate Communications and Investor Relations Director
+46-733-666-599
paula.treutiger@medicover.com
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Meicover acquires leading genetics laboratory in Germany |
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Medicover AB Registered Shs -B-mehr Nachrichten
29.10.24 |
Ausblick: Medicover Registered B präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) | |
15.10.24 |
Erste Schätzungen: Medicover Registered B gewährt Anlegern Blick in die Bücher (finanzen.net) | |
24.07.24 |
Ausblick: Medicover Registered B verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
10.07.24 |
Erste Schätzungen: Medicover Registered B stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) |